Pharmatech Associates Adds Biotech Leader Praveen Tyle to Board of Trustees
Pharmatech Associates Showcases Strategic Program Development for Drug Sponsors and Innovators at CPHI Barcelona 2023
HAYWARD, Calif.--(BUSINESS WIRE)--The Board of Directors of Pharmatech Associates today announced the appointment of Sireesha Yadlapalli as chief executive officer, effective June 5, 2023. Ms. Yadlapalli will succeed Bikash Chatterjee, who will remain with the organization as President and chief science officer.
USP/Pharmatech to Provide Pharmaceutical Continuous Manufacturing Capabilities for Drug Developers and Manufacturers
IRVING, Texas, May 1, 2019 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that it has acquired Pharmatech, Inc., a pioneer of the original Just-In-Time research system with the largest research-ready oncology network. With this strategic acquisition, Caris is changing the paradigm from the traditional physician outreach model to a real-time approach where patient identification is completed at the lab and the physician is informed so that the patient can be enrolled days earlier, and remain in the local physician's care, without having to travel to a large central trial site.
Enforcement Report - Week of January 24, 2018
The regulatory agency said the liquid drugs and dietary supplement products produced by the Davie, Florida-based manufacturer could be potentially contaminated with the bacteria Burkholderia cepacia, which could cause severe patient infection.
Rugby Laboratories Issues Voluntary Nationwide Recall of Diocto Liquid and Diocto Syrup Manufactured By PharmaTech, LLC Due to Possible Product Contamination
Catalent Pharma Solutions has said it will increase spray drying capacity at a plant owned by recent acquisition Pharmatek Laboratories.
PharmaTech LLC Issues Voluntary Nationwide Recall Due to Potential Risk of Product Contamination